MitraClip® Registry

N/ARecruitingNCT02033811

Klinik für Kardiologie, Pneumologie und Angiologie200 enrolled

Overview

Percutaneous mitral valve repair with the MitraClip® system has emerged as a therapeutic alternative to surgical valve repair (PMVR) in high risk patients. The aim of this registry is to collect prospectively and systematically clinical research data from patients undergoing PMVR with the MitraClip® system. This registry is an open-end observational study to assess the characteristics and outcomes patients with severe mitral regurgitation undergoing PMVR.

Study Type

OBSERVATIONAL

Enrollment

200

Conditions

Mitral Regurgitation

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * severe mitral regurgitation * percutaneous mitral valve repair (PMVR) with the MitraClip® system Exclusion Criteria: * \< 18 years * Patients considered by the heart team to be unlikely to receive meaningful or durable clinical benefit from the procedure

Locations (1)

Heinrich Heine University Div. of Cardiology, Pulmonary Disease and Vasculae Medicine

Düsseldorf, Germany

RECRUITING

Outcomes

Primary Outcomes

Major cardiac adverse events

increase in the 30-day risk of adverse events among patients receiving PMVR

Time frame: 30 days

Secondary Outcomes

Mortality

Proportion of patients who are alive at 1 year after receiving

Time frame: 1 year

Central Contacts

Malte Kelm, MD

CONTACT

0049 211 81 18800

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.